Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3500166013 | Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3679624011 | Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Hydroflumethiazide and spironolactone only product in oral dose form | true | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Plays role | Potassium-sparing diuretic therapeutic role | true | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Hydroflumethiazide- and spironolactone-containing product | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Diuretic | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Hydroflumethiazide | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Spironolactone-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Some | 1 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has BoSS | Spironolactone | true | Inferred relationship | Some | 1 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Hydroflumethiazide | false | Inferred relationship | Some | 2 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has BoSS | Hydroflumethiazide | true | Inferred relationship | Some | 2 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 2 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Spironolactone | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has active ingredient | Hydroflumethiazide | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has precise active ingredient | Hydroflumethiazide | true | Inferred relationship | Some | 2 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Has precise active ingredient | Spironolactone | true | Inferred relationship | Some | 1 | |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Is a | Hydroflumethiazide- and spironolactone-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets